covid 19 News and Research

RSS

Receiving unemployment insurance reduces a person's risk of food insecurity

Another wave of COVID-19 is putting millions out of work, while tens of millions more remain unemployed, and Congress debates aid.

30 Jan 2021

Study shows BioNTech-Pfizer COVID-19 vaccine's ability to neutralize UK viral variant

In a study evaluating the BioNTech-Pfizer COVID-19 vaccine's ability to neutralize the B.1.1.7 ("UK") viral variant, researchers found no loss of immune protection compared to that against the original Wuhan reference strain.

29 Jan 2021

Startup develops yeast-based test to detect the presence of SARS-CoV-2 in saliva

Incubated at the University of Campinas (UNICAMP) in the state of São Paulo, Brazil, and supported by São Paulo Research Foundation- FAPESP's Innovative Research in Small Business Program (PIPE), BIOinFOOD is a startup that is developing a rapid COVID-19 diagnostic test based on a patent application filed by students at UNICAMP's Genomics and Bioenergy Laboratory.

29 Jan 2021

New forecasts show possibility of spike in COVID-19 cases and deaths in the spring

The latest COVID-19 forecasts from the Institute for Health Metrics and Evaluation at the University of Washington now incorporate two new virus variants.

29 Jan 2021

County-level sociodemographic risk factors associated with COVID-19 incidence and mortality

In just one year, COVID-19 has killed more than 400,000 Americans, and infected more than 24 million others. But a new study shows just how unevenly those deaths and cases have played out across the country.

29 Jan 2021

Salk's NOMIS Center receives $9.5 million to grow and expand in health, immunity research

As we endure a global viral pandemic, our appreciation for health and immunity has never been greater. Now, thanks to a generous gift from the NOMIS Foundation, Salk's NOMIS Center for Immunobiology and Microbial Pathogenesis will receive $9.5 million to grow and expand, while continuing to be a leader in health and immunity research.

29 Jan 2021

New COVID-19 test uses a smartphone microscope to quickly analyze saliva samples

Researchers at the University of Arizona are developing a COVID-19 testing method that uses a smartphone microscope to analyze saliva samples and deliver results in about 10 minutes.

29 Jan 2021

Scientists engineer potent trivalent inhibitors of thrombin

Thrombosis, the clogging of blood vessels, is a major cause of heart attacks and embolism. Scientists have now engineered the first inhibitors of thrombin, a protease promoting thrombosis, that is three-fold efficient.

29 Jan 2021

Researchers explore adaptive immunity against human coronaviruses

A recent study shows that long-term adaptive immunity to endemic coronaviruses is widespread, but low in magnitude, and that it shares phenotypic features of spike-specific antibodies and T cell memory across all tested coronaviruses.

29 Jan 2021

What are the main drivers of COVID-19 vaccine hesitancy?

A study conducted in the UK has examined attitudes towards vaccination protecting against COVID-19 and highlighted some of the main drivers of willingness or unwillingness to be immunized.

29 Jan 2021

U.S. public divided over COVID-19 “immunity passports” idea

A nationally representative survey conducted in the U.S. suggests that the public is fairly evenly divided in its support of immunity certificates or “passports” to enable the selective lifting of restrictions placed on people during the COVID-19 pandemic.

29 Jan 2021

What are the natural origins of SARS-CoV-2?

Researchers from the UK and China performed a comprehensive analysis of horseshoe bat and pangolin Sarbecoviruses to shed light on the origins of SARS-CoV-2.

29 Jan 2021

New gene-based vaccine strategy receives grant from the Bill & Melinda Gates Foundation

The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation.

29 Jan 2021

Vitamins and other antiviral drugs may help combat COVID-19

Evidence is emerging that vitamin D - and possibly vitamins K and A - might help combat COVID-19. A new study from the University of Bristol published in the journal of the German Chemical Society Angewandte Chemie has shown how they - and other antiviral drugs - might work.

29 Jan 2021

covid 19 News and Research

Receiving unemployment insurance reduces a person's risk of food insecurity

Study shows BioNTech-Pfizer COVID-19 vaccine's ability to neutralize UK viral variant

Startup develops yeast-based test to detect the presence of SARS-CoV-2 in saliva

New forecasts show possibility of spike in COVID-19 cases and deaths in the spring

County-level sociodemographic risk factors associated with COVID-19 incidence and mortality

Salk's NOMIS Center receives $9.5 million to grow and expand in health, immunity research

New COVID-19 test uses a smartphone microscope to quickly analyze saliva samples

Scientists engineer potent trivalent inhibitors of thrombin

Researchers explore adaptive immunity against human coronaviruses

What are the main drivers of COVID-19 vaccine hesitancy?

U.S. public divided over COVID-19 “immunity passports” idea

What are the natural origins of SARS-CoV-2?

New gene-based vaccine strategy receives grant from the Bill & Melinda Gates Foundation

Vitamins and other antiviral drugs may help combat COVID-19

Pandemic sends a couple into indefinite long distance though just miles apart

New study explores the impacts of emerging "COVID-19 behavioral identities"

As vaccine rollout expands, Black Americans still left behind

Kids already coping with mental disorders spiral as pandemic topples vital support systems

Study finds protective genetic associations with mild COVID-19

Vaccination chaos fuels push to recall Newsom

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News